Company intelligence / Profile preview

Organogenesis

Canton, Massachusetts, United Statesorganogenesis.com ↗

Ownership: Public · ORGO
Employees: ~862
Development stage: Other

Overview

Organogenesis has established itself as a leader in regenerative medicine with multiple FDA-approved products for advanced wound care. Its flagship product Apligraf® was the first living cell therapy approved by the FDA to treat both diabetic foot ulcers and venous leg ulcers. The company’s portfolio includes several commercialized products addressing acute/chronic wounds and surgical needs. It also has an advanced pipeline with ReNu in Phase III trials targeting knee osteoarthritis.

Therapeutic areas: DermatologyEndocrinologyOtherRheumatologyCardiovascular
Modalities: Living cell-based therapies (e.g., Apligraf®, Dermagraft®)Allogeneic tissue matrices (e.g., NuShield®, Affinity®)Antimicrobial wound matrices (e.g., PuraPly® AM)Injectable biologics (e.g., ReNu)
Industry: Biotech

Drug pipeline

14 assets

allogeneic cultured keratinocytes and fibroblasts in bovine collagen

Approved

13 more assets in the full pipeline.

Request access →

Partnerships

Strategic partnerships not specifically listed; company collaborates broadly across hospitals, clinics, government facilities.

Financials

Market cap: $202M
Total revenue: $43.8M
Enterprise value: $222.9M

Beyond the preview

Go deeper on Organogenesis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Organogenesis.

Explore the full profile